Not investment advice.Read full disclaimer
Continue with finqOS
Side-by-side valuation, growth, and profitability metrics against the closest competitors.
14-day free trial · No credit card required
52W Range
Volume
Mkt Cap
P/E
Div Yield
Publicly traded Piramal Pharma Limited (PPLPHARMA.NS) competitors and peer companies. Compare valuation, revenue growth, margins, and profitability against J. B. Chemicals & Pharmaceuticals Limited, J. B. Chemicals & Pharmaceuticals Limited, Inventurus Knowledge Solutions Ltd., Inventurus Knowledge Solutions Ltd., Dr. Lal PathLabs Limited, and more.
| Ticker | Company | Market Cap |
|---|---|---|
| JBCHEPHARM.NS | J. B. Chemicals & Pharmaceuticals Limited | $369.6B |
| JBCHEPHARM.BO | J. B. Chemicals & Pharmaceuticals Limited | $366.7B |
| IKS.BO | Inventurus Knowledge Solutions Ltd. | $282.8B |
| IKS.NS | Inventurus Knowledge Solutions Ltd. | $282.8B |
| LALPATHLAB.BO | Dr. Lal PathLabs Limited | $273.9B |
| LALPATHLAB.NS | Dr. Lal PathLabs Limited | $273.1B |
| ASTRAZEN.NS | AstraZeneca Pharma India Limited | $205.6B |
| SYNGENE.NS | SYNGENE.NS | — |
| SYNGENE.BO | SYNGENE.BO | — |
| PEL.NS | PEL.NS | — |